Advertisement

Related Videos

David A. Hyman, MD, JD, on Inclusive Shared Savings

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Peter Clark, MA, MD, FRCP: A Payer Perspective

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Oct
30
Today In Oncology
ASTRO Updates Guideline on Shorter-Course Radiation Therapy for Localized Prostate Cancer
High-Risk Melanoma Personalized mRNA Vaccine Plus Immunotherapy Reduces Risk of Recurrence After Surgery
Selpercatinib Sacituzumab Govitecan Show Activity in Thyroid Cancer Subtypes
TALENT Neoadjuvant T-DXd in HER2-Low Early Breast Cancer
Financial Navigation Program May Help Reduce Cancer-Related Financial Hardship
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo